2024-04-25 09:18:10 ET
More on Standard BioTools
- Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript
- Standard BioTools enters strategic engagement with Bristol Myers for expanded use of SomaScan platform
- Standard BioTools exchanges all outstanding Series B convertible preferred stock for common stock
- Seeking Alpha’s Quant Rating on Standard BioTools
- Historical earnings data for Standard BioTools
Read the full article on Seeking Alpha
For further details see:
Standard Biotools announces operational restructuring plan including headcount reduction